237 related articles for article (PubMed ID: 30694777)
1. Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
Wang E; Chomsky-Higgins K; Chen Y; Nwaogu I; Seib CD; Shen WT; Duh QY; Suh I
J Surg Res; 2019 Apr; 236():37-43. PubMed ID: 30694777
[TBL] [Abstract][Full Text] [Related]
2. Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea.
Wolley MJ; Pimenta E; Calhoun D; Gordon RD; Cowley D; Stowasser M
J Hum Hypertens; 2017 Sep; 31(9):561-567. PubMed ID: 28382959
[TBL] [Abstract][Full Text] [Related]
3. Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study.
Buffolo F; Li Q; Monticone S; Heinrich DA; Mattei A; Pieroni J; Mei M; Yang S; Hu YH; Yang MC; Sabbadin C; Pizzolo F; Giacchetti G; Fallo F; Veglio F; Reincke M; Wu VC; Mulatero P
Hypertension; 2019 Dec; 74(6):1532-1540. PubMed ID: 31679423
[TBL] [Abstract][Full Text] [Related]
4. Primary aldosteronism and obstructive sleep apnea: A single-center cross-sectional study of the Japanese population.
Nakamura Y; Kobayashi H; Tanaka S; Hatanaka Y; Fuke Y; Fukuda N; Abe M
Medicine (Baltimore); 2021 Mar; 100(11):e25049. PubMed ID: 33725980
[TBL] [Abstract][Full Text] [Related]
5. Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?
Prejbisz A; Kołodziejczyk-Kruk S; Lenders JWM; Januszewicz A
Horm Metab Res; 2017 Dec; 49(12):969-976. PubMed ID: 29202496
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary aldosteronism in patients with concomitant hypertension and obstructive sleep apnea, baseline data of a cohort.
Heizhati M; Aierken X; Gan L; Lin M; Luo Q; Wang M; Hu J; Maimaiti N; Duiyimuhan G; Yang W; Yao L; Zhu Q; Li N
Hypertens Res; 2023 Jun; 46(6):1385-1394. PubMed ID: 36882631
[TBL] [Abstract][Full Text] [Related]
8. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Characteristics of Obstructive Sleep Apnea and Comorbid Primary Aldosteronism].
Shen YY; Zhu J; Shi Y; Tan L; Li TM; Lei F; Tang XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):304-309. PubMed ID: 36949690
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence and clinical characteristics of obstructive sleep apnea in patients with primary hyperaldosteronism].
Mei M; Feng ZP; Song Y; He WW; Cheng QF; Yang SM; Hu JB; Wang KR; Xu ZX; Du ZP; Li QF
Zhonghua Nei Ke Za Zhi; 2020 Nov; 59(11):866-871. PubMed ID: 33120490
[No Abstract] [Full Text] [Related]
11. Screening for Primary Aldosteronism Among Hypertensive Adults with Obstructive Sleep Apnea: A Retrospective Population-Based Study.
Hundemer GL; Imsirovic H; Kendzerska T; Vaidya A; Leung AA; Kline GA; Goupil R; Madore F; Agharazii M; Knoll G; Sood MM
Am J Hypertens; 2023 Jun; 36(7):363-371. PubMed ID: 36827468
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
13. Primary aldosteronism and obstructive sleep apnea: A meta-analysis of prevalence and metabolic characteristics.
Zhang R; Cai X; Lin C; Yang W; Lv F; Han X; Ji L
Sleep Med; 2024 Feb; 114():8-14. PubMed ID: 38142557
[TBL] [Abstract][Full Text] [Related]
14. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a formal sleep center-based screening protocol for primary aldosteronism in patients with obstructive sleep apnea.
Wright K; Mahmoudi M; Agrawal N; Simpson H; Lui MS; Pachter HL; Patel K; Prescott J; Suh I
Surgery; 2023 Jan; 173(1):59-64. PubMed ID: 36198493
[TBL] [Abstract][Full Text] [Related]
17. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564
[TBL] [Abstract][Full Text] [Related]
18. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea.
Dobrowolski P; Kołodziejczyk-Kruk S; Warchoł-Celińska E; Kabat M; Ambroziak U; Wróbel A; Piekarczyk P; Ostrowska A; Januszewicz M; Śliwiński P; Lenders JWM; Januszewicz A; Prejbisz A
J Clin Sleep Med; 2021 Apr; 17(4):629-637. PubMed ID: 33135629
[TBL] [Abstract][Full Text] [Related]
20. Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea.
Conroy PC; Hernandez S; Graves CE; Menut KC; Pearlstein S; Liu C; Shen WT; Gosnell J; Sosa JA; Roman S; Duh QY; Suh I
Am J Med; 2022 Jan; 135(1):60-66. PubMed ID: 34508708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
